The DMC funds two new COVID-19 Development Grants

The COVID-19 pandemic has quickly raised a wide range of clinical, translational, and basic research questions. The DMC responded by organizing a new urgent request for applications for DMC COVID-19 Development Grants to support innovative research projects that address the microbiome and COVID-19. Following an accelerated review process, the DMC is pleased to announce that two projects have been awarded – one led by Drs. Antony Sung and Paul Wischmeyer that explores the possibility of using probiotics to reduce SARS-CoV-2 transmission in exposed household contacts, and one led by Dr. Matthew Kelly to explore the impact of the gut and respiratory microbiota on susceptibility to SARS-CoV-2 in children.